Skip to main content

The MMR saga: blinding or fooling the public with science?

mainly because of the studies of one researcher. Susan Mayor assesses the evidence.

Written bySusan Mayor
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00

LONDON The UK government earlier this week announced a major publicity campaign to reassure parents about the safety of the MMR (measles, mumps and rubella) vaccine, after a unique high-level summit was held to work out how to regain public confidence. The vaccine has become controversial because of claims — based on studies lead by one researcher, Andrew Wakefield, a consultant gastroenterologist at the Royal Free Hospital, London — that it might be linked to autism and bowel disease.

The MMR controversy was triggered initially by a study published in 1998, which claimed to show that MMR is linked to autism and intestinal abnormalities (Lancet 1998, 351:637–641). The study assessed 12 children who were referred to a paediatric gastroenterology unit with a history of normal development followed by loss of acquired skills, including language, together with diarrhoea and abdominal pain. The researchers reported that the parents associated the onset of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo